NATCOPHARMBSENatco Pharma LtdMediumNeutral
Announced Thu, 21 May · 12:23 IST

Q4FY26 Audited Financial Results Earnings Call

Board & Shareholder Meetings View source PDF

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹1157.00
prior close
₹1163.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.4+0.7+0.8+1.1+1.8+2.7+1.9-13.1-18.6-25.3-23.7-16.9
Up moveDown movePending
AI summary

Natco Pharma will host an earnings call on Friday, May 29, 2026 at 16:30 PM IST to discuss its Q4FY26 and full-year FY26 audited financial results (year ended 31 March 2026). The call is hosted by 360 ONE Capital Market Private Limited. Key management participants include Vice-chairman and CEO Rajeev Nannapaneni, CFO Amit Parekh, and Executive Vice President Rajesh Chebiyam. The filing is dated 21 May 2026 and includes conference dial-in details for India and multiple international numbers.

Likely market impact

This is a routine earnings call announcement and does not contain any financial results or material guidance. Investors can use the call to engage with management on Q4 and full-year performance once results are disclosed.